A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study - Test2 - elhamkhani - TriplyDB

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

http://www.wikidata.org/entity/Q24651897

about

High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia Acute lymphoblastic leukaemia New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia Genetic abnormalities associated with acute lymphoblastic leukemia Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute Leukemia Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase Diagnosis and subclassification of acute lymphoblastic leukemia Genomic profiling of B-progenitor acute lymphoblastic leukemia Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine A health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigm Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomab IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.Integrating cancer genomic data into electronic health records Recent advances and novel treatment paradigms in acute lymphocytic leukemia Childhood acute lymphoblastic leukemia: Integrating genomics into therapy Prognostification of ALL by Cytogenetics Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic target Use of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemia The leukemia-specific fusion gene ETV6/RUNX1 perturbs distinct key biological functions primarily by gene repression Germline genomic variants associated with childhood acute lymphoblastic leukemia Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia.The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, 6-7 May 2009.Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.Filtering, FDR and power.Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia.Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia.Childhood B-acute lymphoblastic leukemia: a genetic update.Regulatory network of GATA3 in pediatric acute lymphoblastic leukemia Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistance

P2860

Q23749304-21A86F05-24D0-4FB5-B801-4311E4C49168 Q24597084-B5C07EA5-3F6E-438D-B3AD-7845CEED900B Q24602387-9F5ADEDA-1109-495E-8375-E24B4E352871 Q26749177-28C3FDD8-43A5-4EEB-A660-4598DCF8C3DB Q26753823-895D090D-9398-42B9-B394-109951CEB462 Q26781328-B8447FB9-8B32-41FC-B3BE-2E3B1A438B1A Q26784116-072EAD55-B419-4328-89BA-2C821443B41C Q26824387-01D16928-9FCA-4CDC-86B9-193E7E946C67 Q26829976-5BA0BECF-DB4A-4638-ADF9-73E289304962 Q26864460-3853D2CA-77A9-41D8-98EC-980F3B2FB177 Q26866379-95FAFAD2-4E50-4D43-AE91-42688899DA0C Q27013710-1C9292C9-D8A6-4278-87CD-E5E109324DF6 Q27851563-BEB8E812-10EB-4912-A134-B4E26885CC4D Q27853366-33CDBE93-AB58-46B3-8D0B-964D06CDDD2B Q28077310-BF9AA204-D98B-460D-A05F-1266FA5F3026 Q28078076-DA5CDF0D-35DC-4785-BC2F-684BC6A49468 Q28080463-F7F8A05E-CE94-4018-9722-663AC315519C Q28087446-64332A70-E6E4-46D7-A689-CA8224351DDD Q28087637-C22DB3DA-A957-4BC8-9A50-6A91104EC53D Q28306608-925F681A-4DF2-4004-BE51-E6434D9B3DFF Q28390558-84F41EF1-D65F-4FDE-9DC7-FE78BAAD511D Q28743650-EDB6ED0E-317E-4FA4-A197-CA93E1EC65F1 Q28924384-9F815834-63CE-4B72-A59D-2043F51B8BF0 Q28943431-2710F829-00B4-4A16-8E75-DE85D34F82C6 Q30842603-F54D763B-1029-4B05-8FC4-BBA0E8FE1AC7 Q33422654-E39AE439-D7B2-4875-85D1-78D02DEC7B57 Q33573735-9C4FE396-5497-4684-855B-02CB8A3177CA Q33578333-115E5CC5-8624-4845-8F5F-A6139E1B49FB Q33586588-109F053E-4500-48C2-9798-2072E5864269 Q33636082-620A054C-D36F-4065-9AB1-D81607EA1E9E Q33645862-1B725C8D-9DA6-4E50-A6B7-8E61E6792AA8 Q33680280-C5E96C85-A2AD-42A1-933C-2AB8CA2FCCF6 Q33686432-9622019A-9193-4C0A-8D4E-7E55C344F6CD Q33688248-D5EB72A3-E086-432C-BC76-E9433D643720 Q33705933-F2704B20-F875-4A30-8528-ECB75111FABC Q33711119-FFAAA940-8400-49F1-833F-C3F7A137394B Q33746736-59258EB1-FFDF-4C75-B2EC-87CD13ECBEB5 Q33777616-9576CDD3-EE50-491A-8E63-688989491B45 Q33829399-F5801B88-3815-47E5-9417-E0B1DFFC0F01 Q33879498-EC2077E2-42A1-4A99-AA9A-F4C4A65942FE

P2860

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

http://www.wikidata.org/entity/Q24651897

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A subtype of childhood acute l ...... nome-wide classification study

@ast

A subtype of childhood acute l ...... nome-wide classification study

@en

A subtype of childhood acute l ...... nome-wide classification study

@nl

type

label

A subtype of childhood acute l ...... nome-wide classification study

@ast

A subtype of childhood acute l ...... nome-wide classification study

@en

A subtype of childhood acute l ...... nome-wide classification study

@nl

prefLabel

A subtype of childhood acute l ...... nome-wide classification study

@ast

A subtype of childhood acute l ...... nome-wide classification study

@en

A subtype of childhood acute l ...... nome-wide classification study

@nl

P1433

Q24651897-DA05A01D-F2DB-4042-B7AB-9DC7E2D1E1C3

P1476

Q24651897-0F0F01C8-60A7-4133-B27D-D5FC1BF93AAF

P2093

Q24651897-17FA04AA-E9BA-4B2A-95E3-68BF352C6DE6

Q24651897-3037B0D3-BBD2-419C-BEF8-3F0AA5DFDA72

Q24651897-425FF01C-CAFD-4C51-8EE8-2AF8F1504FB4

Q24651897-55035AFB-7261-4BBE-B236-CF9DED63933E

Q24651897-5D7B4CCC-D3F7-4F96-BC5E-12C181BB63D0

Q24651897-792A2200-EF2F-410F-A474-B2C73D42A311

Q24651897-9EBF9A88-7F85-4FE1-A18F-69C456AB6FB5

Q24651897-A38C2827-94A3-47A6-96BB-FCE5B56429DB

Q24651897-A3AB47B2-7EC0-4038-9396-1F3CAC1B1A37

Q24651897-CB7AC577-389B-4BF0-A1C7-C267BA96ED67

P2860

Q24651897-02E9AA1C-A7EE-462C-AAB2-4826FE63D6F2

Q24651897-06C89626-A4B1-4F2F-BE24-60771CC00212

Q24651897-071D4045-F840-4E1C-9877-BC5D765BEC17

Q24651897-1F49D5A0-BCA3-4657-A958-D6053771882B

Q24651897-206460D9-8FFA-4D2A-BDFC-FE57D495FEEC

Q24651897-276BBE92-1390-4BEE-A7AB-E7DD6C8C9784

Q24651897-375C629A-9FD1-44D0-A064-10EBC2806751

Q24651897-6E45C8A4-BA41-40F5-B881-7DC9ECD949CF

Q24651897-6EE36B2E-6C06-41E6-AB8F-03549A2C8AAB

Q24651897-79EBE79A-44D9-4F6B-AC6A-72403DB0F813

P304

Q24651897-94447F34-4FC0-49BE-9364-9B1207B33592

P31

Q24651897-AF3E58C7-E9D5-4B46-943E-0D3CC6253248

P3181

Q24651897-75C7D83F-3DE6-4059-8209-FE42B37D2C5C

P356

Q24651897-37DAC07E-AF78-4F7C-AE1F-0B9301D117DF

P407

Q24651897-BEF466D8-2C55-4AAA-B476-1D0CCEEE6CEF

P433

Q24651897-8A8FACB9-7016-431B-A516-DEF849901E84

P478

Q24651897-63DDD810-AF03-476D-863E-BC948D5C1572

P50

Q24651897-2F8E8BAE-46A8-4A65-B937-B7412C505B83

P577

Q24651897-26CC882E-1DCC-49C2-B316-834D1B406422

P698

Q24651897-5F682C20-7029-43E7-8B32-BE0CA6EB8247

P921

Q24651897-E80E3874-82D7-4E75-B186-F4347BDDEDB1

P932

Q24651897-90D5FB64-7C01-4E27-8F7C-7371C4DB209C

P3181

P356

S1470-2045(08)70339-5

P1433

The Lancet Oncology

P1476

A subtype of childhood acute l ...... nome-wide classification study

@en

P2093

Gaby Escherich

http://www.w3.org/2001/XMLSchema#string

Gritta E Janka-Schaub

http://www.w3.org/2001/XMLSchema#string

H Berna Beverloo

http://www.w3.org/2001/XMLSchema#string

Jessica G C A M Buijs-Gladdines

http://www.w3.org/2001/XMLSchema#string

Laura J C M Van Zutven

http://www.w3.org/2001/XMLSchema#string

Marjon van Slegtenhorst

http://www.w3.org/2001/XMLSchema#string

Martin A Horstmann

http://www.w3.org/2001/XMLSchema#string

Meyling H Cheok

http://www.w3.org/2001/XMLSchema#string

Monique L Den Boer

http://www.w3.org/2001/XMLSchema#string

Peter J Van der Spek

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

Selection bias in gene extraction on the basis of microarray gene-expression data.

Biology and treatment of acute lymphoblastic leukemia.

Prospective gene expression analysis accurately subtypes acute leukaemia in children and establishes a commonality between hyperdiploidy and t(12;21) in acute lymphoblastic leukaemia.

A global test for groups of genes: testing association with a clinical outcome.

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia.

P304

125-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1014843

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S1470-2045(08)70339-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19138562

http://www.w3.org/2001/XMLSchema#string

P921

P932

2707020

http://www.w3.org/2001/XMLSchema#string